Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
METFORMIN HYDROCHLORIDE
APOTEX INC
A10BA02
METFORMIN
850MG
TABLET
METFORMIN HYDROCHLORIDE 850MG
ORAL
15G/50G
Prescription
Active ingredient group (AIG) number: 0101773002; AHFS:
APPROVED
2022-06-01
_ _ _Page 1 of 39 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR METFORMIN TABLETS Metformin Hydrochloride Tablets, BP 500 mg, 850 mg Oral Antihyperglycemic Agent APOTEX INC. 150 Signet Drive Toronto, Ontario M9L 1T9 Date of Preparation: May 30, 2022 Submission Control No.: 263024 _Page 2 of 39_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................ 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 4 WARNINGS AND PRECAUTIONS ........................................................................................ 5 ADVERSE REACTIONS ........................................................................................................ 12 DRUG INTERACTIONS ......................................................................................................... 15 DOSAGE AND ADMINISTRATION ..................................................................................... 17 OVERDOSAGE ....................................................................................................................... 19 ACTION AND CLINICAL PHARMACOLOGY ................................................................... 20 STORAGE AND STABILITY ................................................................................................ 20 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................... 21 PART II: SCIENTIFIC INFORMATION .............................................................................. 22 PHARMACEUTICAL INFORMATION ................................................................................ 22 CLINICAL TRIALS .................................................................................. Կարդացեք ամբողջական փաստաթուղթը